Together, we will unlock better treatments for autoimmune diseases.
Find better treatment options Advance diagnosis & research
Autoimmune diseases are complex.
Advancing treatments doesn't have to be.
From your very first symptom to your eventual diagnosis and treatment, your unique autoimmune journey has accumulated valuable data that tells a story that could lead to better treatments. Unfortunately, this story is trapped in various health systems and sits there, unused. As the patient, you have the power to unlock this data.
With your permission, DrugViu will find and consolidate all your medical records and return them back to you on your own secure portal, for free. There, you'll have a holistic view of your entire health history, while also having the power to share your records with current and future medical providers. You'll also have the option of contributing your de-identified and anonymized data to scientists and doctors working to find better treatments and improve the diagnosing process. Together, we will power tomorrow's cures.
New Update

Introducing: IntroducingViuhealth

THE FIRST DIGITAL CHRONIC CARE MANAGEMENT SOLUTION FOR AUTOIMMUNITY BY DRUGVIU.

With DrugViu, we consolidated your medical records and connect you to clinical trials. Now, with ViuHealth, we pair you with your personalized autoimmune nurse and nutritionist to help manage your day-to-day condition.

Learn more about how you can access this chronic care app so you can live your best life every day.

Focus Areas
There are over 80 autoimmune diseases. We are working hard to include all of them on our platform.
Your condition not listed? You can still help research...Sign up to contribute.
Acute disseminated encephalomyelitis (ADEM)
Autoimmune encephalitis
Balo concentric sclerosis
Guillain–Barré syndrome (GBS)
Hashimoto’s encephalopathy
Lambert–Eaton myasthenic syndrome (LEMS)
Multiple sclerosis (MS)
Myasthenia gravis (MG)
Neuro-Behçet's disease (NBD)
Neuromyelitis optica spectrum disorder (NMOSD)
Optic neuritis (ON)
Transverse myelitis (TM)
Celiac disease
Crohn’s disease
Ulcerative colitis
Ankylosing spondylitis (AS)
CREST syndrome
Lupus (SLE)
Mixed connective tissue disease (MCTD)
Polymyositis
Rheumatoid arthritis (RA)
Scleroderma (systemic sclerosis)
Sjögren syndrome
Alopecia areata
Atopic dermatitis
Bullous pemphigoid
Hidradenitis suppurativa
Pemphigus
Psoriasis
Vitiligo
Acquired hemophilia
Antiphospholipid syndrome (APS)
Aplastic anemia
Autoimmune cytopenia
Autoimmune hemolytic anemia (AHA)
Autoimmune neutropenia (AIN)
Cold agglutinin disease (CAD)
Evans syndrome
Immune thrombocytopenia (ITP)
Paroxysmal cold hemoglobinuria (PCH)
Pernicious anemia
Vasculitis
Grave's disease
Hashimoto's disease
Hypothyroidism
Type 1 diabetes
Allergies
Asthma
Benefits
At DrugViu, we’re here to make your journey with autoimmune disease easier. Here’s how.

All Your Medical Records In One Place

DrugViu finds and consolidates your entire medical records, provides them back to you on a secure portal, and allows you to share this holistic health history with your new providers.

Find Better Personalized Treatment Options

DrugViu provides you with personalized care options by matching you to the right clinical trials and providing verified medication reviews from people who look like you.

Accelerate Discoveries & Diversify Research

DrugViu gives you the option to contribute your de-identified and anonymized data to multiple research projects, ensuring that treatments work for everyone.
My Dashboard
All your medical records in one place - with the ability to share with your care team.
How It Works

Sign Up

Create a secure account, review our patient privacy policy, and give us your consent (takes 5 minutes).

Our Tech Goes to Work

We find, de-identify and standardize your medical records and make it available to researchers.

Accelerate Research

See your contribution to cutting-edge research and get all your medical records in one place for free.
HIPAA Compliant
Highest privacy and data protections
by United States law
Full Encryption
Bank grade data encryption to fully
protect your privacy
Complete Control
You determine how researchers use
your de-identified data
Accessible
We are always available to answer your questions or concerns
Welcome Message
By joining DrugViu, you are not only joining a community, but also a movement dedicated to eradicating autoimmune diseases. Our movement makes your voice heard, your condition seen, and your journey understood. Collectively, we have the power to move the treatments of today towards the cures of tomorrow.
Our Ambassadors
Hear directly from our community - real people, real stories, real DrugViuers.
Justice
Justice

MS Warrior

Aldelly
Aldelly

NMO Warrior

Nicole
Nicole

Lupus Warrior

Lina
Lina

MS Warrior

Emmitt
Emmitt

Lupus Warrior

Our Story
Less than 5% of autoimmune research participants are people of color. This underrepresentation leads to a lack of understanding about medication performance, disease presentation, and the best treatment options for diverse populations. Confronted with this disparity, Kwaku and Melanie decided to do something about it.
We started DrugViu with three objectives:
1. Bring diversity and inclusion to autoimmune research and data
2. Empower patients to take control of their medical records
3. Enable patients to find new and better treatment options
Today, thousands of patients and leading research organizations trust us to ensure the cures of tomorrow work - for everyone.
Medical Advisory Board
Chris Ho,
Chris Ho, MD/PhD

Medical Advisor

Christine Humblet,
Christine Humblet, PhD

Science Advisor

Anusha Yeshokumar,
Anusha Yeshokumar, MD

Neurology Advisor

University Partners & Investors
Latest News

Coral

Coral Partners with DrugViu to Address Minority Representation in Autoimmune Medicine
March 26, 2021

JLABS

The Power of Diverse Patient Data: An Interview with Kwaku Owusu, Co-Founder & CEO of DrugViu
February 18, 2021

Fast Company

This startup just won $75,000 to bring relevant healthcare information to people of color.
Nov 09, 2019

Chicago Sun Times

Kwaku Owusu: Lack of minorities in drug trials demanded attention, so he launched a company.
Sep 7, 2019